Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$26.39
Market cap
$149.55B
P/E Ratio
34.72
Dividend/share
$1.68
EPS
$0.76
Enterprise value
$216.16B
Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United
Highlights
The gross margin has grown by 17% from the previous quarter and by 11% YoY
The quick ratio has plunged by 69% YoY but it has grown by 33% from the previous quarter
Pfizer's gross profit has increased by 25% from the previous quarter but it has decreased by 3.8% YoY
The price to earnings (P/E) is 84% higher than the 5-year quarterly average of 19.1
Pfizer's EPS has plunged by 59% YoY
Key stats
What are the main financial stats of PFE
Market
Valuations
Earnings
Shares outstanding
5.67B
Market cap
$149.55B
Enterprise value
$216.16B
Price to earnings (P/E)
34.72
Price to book (P/B)
1.62
Price to sales (P/S)
2.49
EV/EBIT
56.15
EV/EBITDA
20.12
EV/Sales
3.6
Revenue
$60.11B
Gross profit
$40.61B
Net income
$4.25B
EBIT
$3.85B
EBITDA
$10.74B
Free cash flow
$8.23B
Per share
Balance sheet
Liquidity
EPS
$0.76
EPS diluted
$0.75
Free cash flow per share
$1.45
Book value per share
$16.29
Revenue per share
$10.61
TBVPS
$16.04
Total assets
$219.48B
Total liabilities
$126.92B
Debt
$67.7B
Equity
$92.29B
Working capital
$12M
Debt to equity
0.73
Current ratio
1
Quick ratio
0.56
Net debt/EBITDA
6.2
Margins
Efficiency
Dividend
EBITDA margin
17.9%
Gross margin
67.6%
Net margin
7.1%
Operating margin
6.5%
Return on assets
1.9%
Return on equity
4.7%
Return on invested capital
3.4%
Return on capital employed
2.2%
Return on sales
6.4%
Dividend yield
6.37%
DPS
$1.68
Payout ratio
221.1%
PFE stock price
How has the Pfizer stock price performed over time
Intraday
-0.94%
1 week
0.65%
1 month
0.11%
1 year
-6.78%
YTD
-0.53%
QTD
-0.53%
Financial performance
How have Pfizer's revenue and profit performed over time
Revenue
$60.11B
Gross profit
$40.61B
Operating income
$3.9B
Net income
$4.25B
Gross margin
67.6%
Net margin
7.1%
The operating income has soared by 194% from the previous quarter but it has plunged by 63% YoY
The company's operating margin has surged by 188% QoQ but it has shrunk by 57% YoY
Pfizer's net income has shrunk by 59% YoY
PFE's net margin has plunged by 53% YoY
Growth
What is Pfizer's growth rate over time
Valuation
What is Pfizer stock price valuation
P/E
34.72
P/B
1.62
P/S
2.49
EV/EBIT
56.15
EV/EBITDA
20.12
EV/Sales
3.6
The price to earnings (P/E) is 84% higher than the 5-year quarterly average of 19.1
Pfizer's EPS has plunged by 59% YoY
PFE's P/B is 39% below its 5-year quarterly average of 2.7 and 9% below its last 4 quarters average of 1.8
Pfizer's equity has increased by 5% QoQ but it has decreased by 4.8% YoY
PFE's P/S is 28% below its 5-year quarterly average of 3.5 and 10% below its last 4 quarters average of 2.8
Pfizer's revenue has decreased by 13% YoY but it has increased by 8% QoQ
Efficiency
How efficient is Pfizer business performance
The company's return on invested capital has surged by 200% QoQ but it has shrunk by 59% YoY
Pfizer's ROS has soared by 185% from the previous quarter but it has plunged by 57% YoY
Pfizer's ROA has plunged by 63% YoY
The ROE has shrunk by 56% YoY
Dividends
What is PFE's dividend history
DPS
$1.68
Dividend yield
6.37%
Payout ratio
221.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Pfizer financials performed over time
PFE's total assets is 73% greater than its total liabilities
The quick ratio has plunged by 69% YoY but it has grown by 33% from the previous quarter
The current ratio has plunged by 58% YoY but it has grown by 16% from the previous quarter
PFE's debt is 27% less than its equity
The debt to equity has grown by 11% YoY but it has contracted by 8% from the previous quarter
PFE's debt is up by 6% YoY but it is down by 2.5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.